Details

Cross-species upregulation of MAGED2 in liver cancer suggests a role in obesity-driven tumor progression
ID Bayat, Tara (Author), ID Blagotinšek Cokan, Kaja (Author), ID Rozman, Damjana (Author), ID Fon Tacer, Klementina (Author), et al.

.pdfPDF - Presentation file, Download (3,09 MB)
MD5: E94D0D6233D13ABC9279BF34033EB321
URLURL - Source URL, Visit https://www.mdpi.com/1467-3045/48/2/139 This link opens in a new window

Abstract
Melanoma-associated antigens (MAGEs) are cancer-testis antigens (CTAs) aberrantly expressed in multiple cancer types, including hepatocellular carcinoma (HCC), and associated with aggressive phenotypes. Although MAGE proteins are widely studied as cancer immunotherapy targets, their roles in HCC and the regulation of their expression during liver pathogenesis in mouse models, including dietary effects, remain poorly understood. We analyzed Mage gene expression in liver tissues from 78 C3H/HeJ mice with chronic diet-induced obesity. While type I MAGE genes are frequently expressed in human HCC, we found no evidence of their expression in mouse liver tumors, suggesting species-specific regulation. In contrast, type II Maged2, previously reported to be upregulated in human HCC, was significantly increased in mouse liver tumors. Analysis of human HCC samples from The Cancer Genome Atlas (TCGA) database confirmed MAGED2 upregulation and its association with patient prognosis. Together, these findings identify MAGED2 as a conserved marker of liver cancer in both humans and mice and emphasize the importance of cross-species comparative approaches for selecting appropriate models and accurately interpreting results, particularly for CTAs, which often evolved recently and in a species-specific manner.

Language:English
Keywords:cancer-testis antigen, CTA, comparative cancer research, hepatocellular carcinoma, high-fat diet, liver tumors, melanoma-associated antigen, MAGE, obesity
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2026
Number of pages:23 str.
Numbering:Vol. 48, iss. 2, art. 139
PID:20.500.12556/RUL-182429 This link opens in a new window
UDC:616.36-006:613.25
ISSN on article:1467-3045
DOI:10.3390/cimb48020139 This link opens in a new window
COBISS.SI-ID:277413635 This link opens in a new window
Publication date in RUL:11.05.2026
Views:266
Downloads:203
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Current issues in molecular biology
Shortened title:Curr. issues mol. biol.
Publisher:MDPI
ISSN:1467-3045
COBISS.SI-ID:521769497 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:antigen raka testisov, CTA, primerjalne raziskave raka, hepatocelularni karcinom, prehrana z visoko vsebnostjo maščob, tumorji jeter, z melanomom povezan antigen, MAGE, debelost

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0390
Name:Funkcijska genomika in biotehnologija za zdravje

Funder:Empirical Foods Inc.
Project number:A18-0187

Funder:TTUAB
Funding programme:Grants-in-Aid

Funder:Cancer Prevention and Research Institute of Texas
Project number:RR200059

Funder:Texas Tech University
Funding programme:Start-up

Funder:Texas Tech University, School of Veterinary Medicine
Funding programme:Seed award

Funder:TC3R - Texas Center for Comparative Cancer Research

Funder:Foundation for Prader–Willi Syndrome Research
Project number:22-0321

Funder:Foundation for Prader–Willi Syndrome Research
Project number:23-0447

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back